Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb 188Re-HAb18

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

471

HTML

2746

Figures (1-2)

188

Tables (1-4)

206

Sum=3611

Feb 15, 2002 (publication date) through Dec 2, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Feb 15, 2002; 8(1): 69-73
Published online Feb 15, 2002. doi: 10.3748/wjg.v8.i1.69

Full Size Figure Download Figure

Figure 2 Binding assay for determination of immunoreactive fraction of ¹⁸⁸Re-labeled HAb18 F(ab’)₂.

Citation: Lou C, Chen ZN, Bian HJ, Li J, Zhou SB. Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb ¹⁸⁸Re-HAb18. World J Gastroenterol 2002; 8(1): 69-73
URL: https://www.wjgnet.com/1007-9327/full/v8/i1/69.htm
DOI: https://dx.doi.org/10.3748/wjg.v8.i1.69